Scientists at the University of Colorado and National Jewish Health have identified novel compounds that specifically inhibit DksA activity in Gram-negative bacteria. Drugs against DksA have antibiotic activity against several Gram-negative pathogens. Moreover, the newly discovered drugs act against persistent populations of intracellular bacteria and potentiate antimicrobial activity of other antibiotics.
Download Summary Document Here:
http://cuamc.technologypublisher.com/files/sites/cu4379h_ncs.pdf